Peter Greenleaf

Peter Greenleaf currently serves as the chief executive officer (CEO) and member of the Board of Directors of Aurinia, (NASDAQ: AUPH / TSX: AUP), an autoimmune therapeutics company. He has held several other CEO and chairman roles. He is also currently a member of the Board of Directors of Antares Pharmaceuticals, Inc. (NASDAQ: ATRS) and Chairman of the Board of Directors of Biodelivery Sciences International, Inc. (NASDAQ: BDSI).


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Revolo Biotherapeutics

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.


Employees

11-50

Links